As BIO kicks off in Boston, so too does a new magazine, The Journal of Life Sciences. Check out the website at http://www.tjols.com.
Today the site features a commentary by Barack Obama. Here are a few select paragraphs ...
"We know that all human beings are 99.9 percent identical in genetic makeup, but differences in the remaining 0.1 percent hold important clues about the causes of disease and response to drugs. Simply put, the study of genomics will help us learn why some people get sick and others do not, and use this information to better prevent and treat disease."
"The relatively new field of genomics is key to the practice of personalized medicine. Personalized medicine is the use of genomic and molecular data to better target the delivery of health care, facilitate the discovery and clinical testing of new products, and help determine a patient’s predisposition to a particular disease or condition."
"Personalized medicine represents a revolutionary and exciting change in the fundamental approach and practice of medicine."
"Realizing the promise of personalized medicine will require continued federal leadership and agency collaboration; expansion and acceleration of genomics research; a capable genomics workforce; incentives to encourage development of genomic tests and therapies; and greater attention to the quality of genetic tests, direct-to-consumer advertising and use of personal genomic information."
Here's a link to the entire piece:
http://www.tjols.com/web_new_frontier.jsp
If the Senator keeps this up, we may have to invite him to join our organization.
Today the site features a commentary by Barack Obama. Here are a few select paragraphs ...
"We know that all human beings are 99.9 percent identical in genetic makeup, but differences in the remaining 0.1 percent hold important clues about the causes of disease and response to drugs. Simply put, the study of genomics will help us learn why some people get sick and others do not, and use this information to better prevent and treat disease."
"The relatively new field of genomics is key to the practice of personalized medicine. Personalized medicine is the use of genomic and molecular data to better target the delivery of health care, facilitate the discovery and clinical testing of new products, and help determine a patient’s predisposition to a particular disease or condition."
"Personalized medicine represents a revolutionary and exciting change in the fundamental approach and practice of medicine."
"Realizing the promise of personalized medicine will require continued federal leadership and agency collaboration; expansion and acceleration of genomics research; a capable genomics workforce; incentives to encourage development of genomic tests and therapies; and greater attention to the quality of genetic tests, direct-to-consumer advertising and use of personal genomic information."
Here's a link to the entire piece:
http://www.tjols.com/web_new_frontier.jsp
If the Senator keeps this up, we may have to invite him to join our organization.
